{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:32:11Z","timestamp":1758126731079},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although a large number of studies have been conducted in relation to ovarian response and pregnancy after GnRH agonist and GnRH antagonist controlled ovarian hyperstimulation protocols, most of them used single or combinations of a few predictive factors, and none included the stimulation protocol in the multivariable analysis. The present study was thus primarily designed to investigate the predictive value of the stimulation protocol and to analyze the possible relationships between stimulation protocols and treatment outcomes after adjusting for a large set of variables that potentially affect reproductive outcomes. Factors related to pregnancy achievement and predictive of the number of oocytes retrieved and high quality of the embryos obtained were also analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To analyze the impact of GnRH ovarian stimulation protocols on the independent predictors of ovarian response, high quality embryos and clinical pregnancy, two groups out of 278 ICSI treatment cycles were compared prospectively, 123 with a GnRH agonist and 155 with a GnRH antagonist, with multivariable analysis assessing outcomes after adjusting for a large set of variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Antagonists were significantly associated with lower length and total dose of GnRH, lower length of rFSH, and higher numbers of oocytes and high quality embryos, whereas the agonist presented a higher fertilization rate and probability of pregnancy. Significant predictors of retrieved oocytes and high quality embryos were the antagonist protocol, lower female age, lower serum levels of basal FSH and higher total number of antral follicles. Significant predictors of clinical pregnancy were the agonist protocol, reduced number of attempts, increased endometrial thickness and lower female age. The probability of pregnancy increased until 30 years-old, with a decline after that age and with a sharp decline after 40 years-old.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The models found suggest that not only the protocol but also factors as female age, basal FSH, antral follicles, number of attempts and endometrial thickness should be analyzed for counselling patients undergoing an ICSI treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7827-7-5","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T19:19:06Z","timestamp":1233256746000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes"],"prefix":"10.1186","volume":"7","author":[{"given":"F\u00e1tima","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Cristiano","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Margarida F","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Teixeira-da-Silva","sequence":"additional","affiliation":[]},{"given":"Joaquina","family":"Silva","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Barros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"issue":"1","key":"477_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.fertnstert.2005.03.016","volume":"84","author":"J Wilcox","year":"2005","unstructured":"Wilcox J, Potter D, Moore M, Ferrande L, Kelly E: Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril. 2005, 84 (1): 108-117. 10.1016\/j.fertnstert.2005.03.016.","journal-title":"Fertil Steril"},{"issue":"9","key":"477_CR2","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1093\/humrep\/dei086","volume":"20","author":"G Griesinger","year":"2005","unstructured":"Griesinger G, Felberbaum R, Diedrich K: GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod. 2005, 20 (9): 2373-2375. 10.1093\/humrep\/dei086.","journal-title":"Hum Reprod"},{"issue":"7","key":"477_CR3","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"G Borm","year":"2000","unstructured":"The European Orgalutran Study Group, Borm G, Mannaerts B: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod. 2000, 15 (7): 1490-1498. 10.1093\/humrep\/15.7.1490.","journal-title":"Hum Reprod"},{"issue":"3","key":"477_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","volume":"15","author":"C Albano","year":"2000","unstructured":"Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P, The European Cetrorelix Study Group: Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod. 2000, 15 (3): 526-531. 10.1093\/humrep\/15.3.526.","journal-title":"Hum Reprod"},{"issue":"2","key":"477_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","volume":"73","author":"F Olivennes","year":"2000","unstructured":"Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, Nicollet B, Zorn J-R, Bouchard P, Frydman R: Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril. 2000, 73 (2): 314-320. 10.1016\/S0015-0282(99)00524-5.","journal-title":"Fertil Steril"},{"issue":"4","key":"477_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","volume":"16","author":"The European and Middle East Orgalutran Study Group","year":"2001","unstructured":"The European and Middle East Orgalutran Study Group: Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod. 2001, 16 (4): 644-651. 10.1093\/humrep\/16.4.644.","journal-title":"Hum Reprod"},{"issue":"1","key":"477_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","volume":"75","author":"M Fluker","year":"2001","unstructured":"The North American Ganirelix Study Group, Fluker M, Grifo J, Leader A, Nicollet B, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT, Schoolcraft W, Shapiro DB: Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2001, 75 (1): 38-45. 10.1016\/S0015-0282(00)01638-1.","journal-title":"Fertil Steril"},{"issue":"3","key":"477_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","volume":"84","author":"M Arslan","year":"2005","unstructured":"Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S: Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005, 84 (3): 555-569. 10.1016\/j.fertnstert.2005.02.053.","journal-title":"Fertil Steril"},{"issue":"2","key":"477_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","volume":"83","author":"LI Barmat","year":"2005","unstructured":"Barmat LI, Chantilis SJ, Hurst BS, Dickey RP: A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril. 2005, 83 (2): 321-330. 10.1016\/j.fertnstert.2004.06.076.","journal-title":"Fertil Steril"},{"issue":"6","key":"477_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/humrep\/15.6.1211","volume":"15","author":"ER Hernandez","year":"2000","unstructured":"Hernandez ER: Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod. 2000, 15 (6): 1211-1216. 10.1093\/humrep\/15.6.1211.","journal-title":"Hum Reprod"},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","volume":"265","author":"M Ludwig","year":"2001","unstructured":"Ludwig M, Katalinic A, Diedrich K: Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet. 2001, 265: 175-182. 10.1007\/s00404-001-0267-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"477_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","volume":"17","author":"H Al-Inany","year":"2002","unstructured":"Al-Inany H, Aboulghar M: GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod. 2002, 17 (4): 874-885. 10.1093\/humrep\/17.4.874.","journal-title":"Hum Reprod"},{"key":"477_CR13","first-page":"CD001750","volume":"3","author":"HG Al-Inany","year":"2006","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M: Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Systematic Rev. 2006, 3: CD001750-","journal-title":"Cochrane Database Systematic Rev"},{"issue":"6","key":"477_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dml038","volume":"12","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G: Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006, 12 (6): 651-671. 10.1093\/humupd\/dml038.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"477_CR15","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/humrep\/dem270","volume":"22","author":"JA Huirne","year":"2007","unstructured":"Huirne JA, Homburg R, Lambalk CB: Are GnRH antagonists comparable to agonists for use in IVF?. Hum Reprod. 2007, 22 (11): 2805-2813. 10.1093\/humrep\/dem270.","journal-title":"Hum Reprod"},{"issue":"November 23","key":"477_CR16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","volume":"348","author":"A Templeton","year":"1996","unstructured":"Templeton A, Morris JK, Parslow W: Factors that affect outcome of in-vitro fertilisation treatment. The Lancet. 1996, 348 (November 23): 1402-1406. 10.1016\/S0140-6736(96)05291-9.","journal-title":"The Lancet"},{"issue":"3","key":"477_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0015-0282(97)00557-8","volume":"69","author":"M-Y Chang","year":"1998","unstructured":"Chang M-Y, Chiang C-H, Hsieh T-T, Soong Y-K, Hsu K-H: Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998, 69 (3): 505-510. 10.1016\/S0015-0282(97)00557-8.","journal-title":"Fertil Steril"},{"issue":"8","key":"477_CR18","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/humrep\/13.8.2192","volume":"13","author":"A El-Nemr","year":"1998","unstructured":"El-Nemr A, Al-Shawaf T, Sabatini L, Wilson C, Lower AM, Grudzinskas JG: Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer. Hum Reprod. 1998, 13 (8): 2192-2198. 10.1093\/humrep\/13.8.2192.","journal-title":"Hum Reprod"},{"issue":"7","key":"477_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/humrep\/14.7.1752","volume":"14","author":"CH Syrop","year":"1999","unstructured":"Syrop CH, Dawson JD, Husman KJ, Sparks AET, Van Voorhis BJ: Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod. 1999, 14 (7): 1752-1756. 10.1093\/humrep\/14.7.1752.","journal-title":"Hum Reprod"},{"issue":"5","key":"477_CR20","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0015-0282(99)00397-0","volume":"72","author":"H Tinkanen","year":"1999","unstructured":"Tinkanen H, Blauer M, Laippala P, Tuohimaa P, Kujansuu E: Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril. 1999, 72 (5): 932-936. 10.1016\/S0015-0282(99)00397-0.","journal-title":"Fertil Steril"},{"issue":"3","key":"477_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0015-0282(00)00693-2","volume":"74","author":"JL Frattarelli","year":"2000","unstructured":"Frattarelli JL, Bergh PA, Drews MR, Sharara FI, Scott RT: Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril. 2000, 74 (3): 518-524. 10.1016\/S0015-0282(00)00693-2.","journal-title":"Fertil Steril"},{"issue":"9","key":"477_CR22","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/humrep\/15.9.1937","volume":"15","author":"EH Ng","year":"2000","unstructured":"Ng EH, Tang OS, Ho PC: The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum Reprod. 2000, 15 (9): 1937-1942. 10.1093\/humrep\/15.9.1937.","journal-title":"Hum Reprod"},{"issue":"6","key":"477_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/humrep\/deh833","volume":"20","author":"EH Ng","year":"2005","unstructured":"Ng EH, Chan CCW, Tang OS, Ho PC: Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment. Hum Reprod. 2005, 20 (6): 1647-1654. 10.1093\/humrep\/deh833.","journal-title":"Hum Reprod"},{"issue":"3","key":"477_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0015-0282(00)01741-6","volume":"75","author":"P Terriou","year":"2001","unstructured":"Terriou P, Sapin C, Giorgetti C, Hans E, Spach J-L, Roulier R: Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril. 2001, 75 (3): 525-531. 10.1016\/S0015-0282(00)01741-6.","journal-title":"Fertil Steril"},{"issue":"4","key":"477_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/humrep\/17.4.950","volume":"17","author":"S Kupesic","year":"2002","unstructured":"Kupesic S, Kurjak A: Predictors of IVF outcome by three-dimensional ultrasound. Hum Reprod. 2002, 17 (4): 950-955. 10.1093\/humrep\/17.4.950.","journal-title":"Hum Reprod"},{"issue":"1","key":"477_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0015-0282(02)04562-4","volume":"79","author":"C-C Chuang","year":"2003","unstructured":"Chuang C-C, Chen C-D, Chao K-H, Chen S-U, Ho H-N, Yang Y-S: Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003, 79 (1): 63-68. 10.1016\/S0015-0282(02)04562-4.","journal-title":"Fertil Steril"},{"issue":"11","key":"477_CR27","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/humrep\/deg461","volume":"18","author":"P Kovacs","year":"2003","unstructured":"Kovacs P, Matyas S, Boda K, Kaali SG: The effect of endometrial thickness on IVF\/ICSI outcome. Hum Reprod. 2003, 18 (11): 2337-2341. 10.1093\/humrep\/deg461.","journal-title":"Hum Reprod"},{"issue":"4","key":"477_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/humrep\/deg181","volume":"18","author":"B Popovic-Todorovic","year":"2003","unstructured":"Popovic-Todorovic B, Loft A, Lindhard A, Bangsboll S, Andersson AM, Andersen AN: A prospective study of predictive factors of ovarian response in 'standard' IVF\/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod. 2003, 18 (4): 781-787. 10.1093\/humrep\/deg181.","journal-title":"Hum Reprod"},{"issue":"2","key":"477_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0015-0282(02)04675-7","volume":"79","author":"S Shen","year":"2003","unstructured":"Shen S, Khabani A, Klein N, Battaglia D: Statistical analysis of factors affecting fertilization rates and clinical outcome associated with intracytoplasmic sperm injection. Fertil Steril. 2003, 79 (2): 355-360. 10.1016\/S0015-0282(02)04675-7.","journal-title":"Fertil Steril"},{"issue":"4","key":"477_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.fertnstert.2004.02.144","volume":"82","author":"LM Frazier","year":"2004","unstructured":"Frazier LM, Grainger DA, Schieve LA, Toner JP: Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment. Fertil Steril. 2004, 82 (4): 834-840. 10.1016\/j.fertnstert.2004.02.144.","journal-title":"Fertil Steril"},{"issue":"2","key":"477_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.fertnstert.2003.06.027","volume":"81","author":"MAM Hassan","year":"2004","unstructured":"Hassan MAM, Killick SR: Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril. 2004, 81 (2): 384-392. 10.1016\/j.fertnstert.2003.06.027.","journal-title":"Fertil Steril"},{"issue":"2","key":"477_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.fertnstert.2004.06.065","volume":"83","author":"J Urbancsek","year":"2005","unstructured":"Urbancsek J, Hauzman E, Klinga K, Rabe T, Papp Z, Strowitzki T: Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil Steril. 2005, 83 (2): 341-348. 10.1016\/j.fertnstert.2004.06.065.","journal-title":"Fertil Steril"},{"issue":"4","key":"477_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.fertnstert.2006.11.002","volume":"87","author":"W Amir","year":"2007","unstructured":"Amir W, Micha B, Ariel H, Liat L-G, Jehoshua D, Adrian S: Predicting factors for endometrial thickness during treatment with assisted reproductive technology. Fertil Steril. 2007, 87 (4): 799-804. 10.1016\/j.fertnstert.2006.11.002.","journal-title":"Fertil Steril"},{"issue":"7","key":"477_CR34","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/humrep\/17.7.1800","volume":"17","author":"M Sousa","year":"2002","unstructured":"Sousa M, Cremades N, Silva J, Oliveira C, Teixeira da Silva J, Viana P, Ferr\u00e1s L, Barros A: Predictive value of testicular histology in secretory azoospermic subgroups and clinical outcome after microinjection of fresh and frozen-thawed sperm and spermatids. Hum Reprod. 2002, 17 (7): 1800-1810. 10.1093\/humrep\/17.7.1800.","journal-title":"Hum Reprod"},{"issue":"3","key":"477_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2307\/2986270","volume":"43","author":"P Royston","year":"1994","unstructured":"Royston P, Altman DG: Regression using fractional polynomials of continuous covariates:parsimonious parametric modelling. Applied Statistics. 1994, 43 (3): 429-467. 10.2307\/2986270.","journal-title":"Applied Statistics"},{"issue":"11\/12","key":"477_CR36","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/sj.bjc.6690279","volume":"79","author":"W Sauerbrei","year":"1999","unstructured":"Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M, The German breast cancer Study Group (GBSG): Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). British J Cancer. 1999, 79 (11\/12): 1752-1760. 10.1038\/sj.bjc.6690279.","journal-title":"British J Cancer"},{"issue":"2","key":"477_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.fertnstert.2005.09.067","volume":"86","author":"SJ Muasher","year":"2006","unstructured":"Muasher SJ, Abdallah RT, Hubayter ZR: Optimal stimulation protocols for in vitro fertilization. Fertil Steril. 2006, 86 (2): 267-273. 10.1016\/j.fertnstert.2005.09.067.","journal-title":"Fertil Steril"},{"issue":"4","key":"477_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/humupd\/dml001","volume":"12","author":"BC Tarlatzis","year":"2006","unstructured":"Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Devroey P: The Brussels GnRH Antagonist Consensus Workshop Group: GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update. 2006, 12 (4): 333-340. 10.1093\/humupd\/dml001.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"477_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/humupd\/dmn001","volume":"14","author":"TE Verhagen","year":"2008","unstructured":"Verhagen TE, Hendriks DJ, Bancsi LFJMM, Mol BWJ, Broekmans FJM: The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update. 2008, 14 (2): 95-100. 10.1093\/humupd\/dmn001.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"477_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmm034","volume":"14","author":"BCJM Fauser","year":"2008","unstructured":"Fauser BCJM, Diedrich K, Devroey P, The Evian Annual Reproduction (EVAR) Workshop Group 2007: Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008, 14 (1): 1-14. 10.1093\/humupd\/dmm034.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"477_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0015-0282(02)03160-6","volume":"78","author":"V Sharma","year":"2002","unstructured":"Sharma V, Allgar V, Rajkhowa M: Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility. Fertil Steril. 2002, 78 (1): 40-46. 10.1016\/S0015-0282(02)03160-6.","journal-title":"Fertil Steril"},{"issue":"9","key":"477_CR42","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/humrep\/dem183","volume":"22","author":"AME Lintsen","year":"2007","unstructured":"Lintsen AME, Eijkemans MJC, Hunault CC, Bouwmans CAM, Hakkaart L, Habbema JDF, Braat DDM: Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod. 2007, 22 (9): 2455-2462. 10.1093\/humrep\/dem183.","journal-title":"Hum Reprod"},{"issue":"3","key":"477_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0015-0282(01)01972-0","volume":"76","author":"Z Blumenfeld","year":"2001","unstructured":"Blumenfeld Z: Gonadotropin-releasing hormone antagonists instead of agonists: a change for the better?. Fertil Steril. 2001, 76 (3): 443-444. 10.1016\/S0015-0282(01)01972-0.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-7-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:18:29Z","timestamp":1630484309000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-7-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,15]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-7-5","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,15]]},"assertion":[{"value":"23 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}